middle.news
Neurizon Secures Long-Term Australian Patent for NUZ-001 in Neurodegenerative Diseases
9:17am on Tuesday 21st of October, 2025 AEDT
•
Biotechnology
Read Story
Neurizon Secures Long-Term Australian Patent for NUZ-001 in Neurodegenerative Diseases
9:17am on Tuesday 21st of October, 2025 AEDT
Key Points
Australian patent granted for NUZ-001 covering multiple neurodegenerative diseases
Patent protection extended through May 2041 across major global markets
Complements earlier US patent, strengthening global intellectual property portfolio
Plans to enter HEALEY ALS Platform Trial later this year
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE